Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial.

Ohashi, Yasuo; Shiba, Eiichi; Yamashita, Hiroko; Kurebayashi, Junichi; Noguchi, Shinzaburo; Iwase, Hirotaka; Yoshida, Michihiro; Fujimoto, Tsukasa

Ohashi, Yasuo; Shiba, Eiichi; Yamashita, Hiroko; Kurebayashi, Junichi; Noguchi, Shinzaburo; Iwase, Hirotaka; Yoshida, Michihiro; Fujimoto, Tsukasa.

Afiliación

Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, 1-13-27 Kasuga, Bunkyo-ku, Tokyo, 112-8551, Japan. ohashiy.00e@g.chuo-u.ac.jp.
Shiba E; Department of Breast Surgery, Osaka Breast Clinic, Osaka, Japan.
Yamashita H; Department of Breast and Endocrine Surgery, Nagoya City University Hospital, Nagoya, Japan.
Kurebayashi J; Department of Breast Surgery, Hokkaido University Hospital, Sapporo, Japan.
Noguchi S; Department of Breast and Thyroid Surgery, Kawasaki Medical School, Kurashiki, Japan.
Iwase H; Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Yoshida M; Department of Breast and Endocrine Surgery, Kumamoto University, Kumamoto, Japan.
Fujimoto T; Takeda Pharmaceutical Company Limited, Osaka, Japan.

Support Care Cancer ; 26(3): 933-945, 2018 Mar.

Article en En | MEDLINE | ID: mdl-29063390

Asunto(s)

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Neoplasias de la Mama/tratamiento farmacológico; Quimioterapia Adyuvante/métodos; Leuprolida/uso terapéutico; Calidad de Vida/psicología; Tamoxifeno/uso terapéutico; Adulto; Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación; Protocolos de Quimioterapia Combinada Antineoplásica/farmacología; Neoplasias de la Mama/patología; Femenino; Humanos; Leuprolida/administración & dosificación; Leuprolida/farmacología; Persona de Mediana Edad; Premenopausia; Tamoxifeno/administración & dosificación; Tamoxifeno/farmacología; Resultado del Tratamiento

Palabras clave

Adjuvant endocrine therapy; Leuprorelin acetate; Luteinizing hormone-releasing hormone agonist; Premenopausal endocrine-responsive breast cancer; Quality of life

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Tamoxifeno / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Leuprolida / Quimioterapia Adyuvante Tipo de estudio: Clinical_trials / Prognostic_studies / Qualitative_research Aspecto: Patient_preference Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google